Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Changes in skeletal muscle gene expression following clenbuterol administration.

Spurlock DM, McDaneld TG, McIntyre LM.

BMC Genomics. 2006 Dec 20;7:320.

2.
3.
4.

Differential gene expression profile in pig adipose tissue treated with/without clenbuterol.

Zhang J, He Q, Liu QY, Guo W, Deng XM, Zhang WW, Hu XX, Li N.

BMC Genomics. 2007 Nov 26;8:433.

5.

Extracellular signal-regulated kinase pathway is differentially involved in beta-agonist-induced hypertrophy in slow and fast muscles.

Shi H, Zeng C, Ricome A, Hannon KM, Grant AL, Gerrard DE.

Am J Physiol Cell Physiol. 2007 May;292(5):C1681-9. Epub 2006 Dec 6.

PMID:
17151143
6.

Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle.

McDaneld TG, Hannon K, Moody DE.

Am J Physiol Regul Integr Comp Physiol. 2006 Jun;290(6):R1672-82. Epub 2006 Jan 19.

PMID:
16424087
7.

Calpastatin overexpression in the skeletal muscle of mice prevents clenbuterol-induced muscle hypertrophy and phenotypic shift.

Douillard A, Galbes O, Begue G, Rossano B, Levin J, Vernus B, Bonnieu A, Candau R, Py G.

Clin Exp Pharmacol Physiol. 2012 Apr;39(4):364-72. doi: 10.1111/j.1440-1681.2012.05677.x.

PMID:
22300302
8.

Clenbuterol increases muscle fiber size and GATA-2 protein in rat skeletal muscle in utero.

Downie D, Delday MI, Maltin CA, Sneddon AA.

Mol Reprod Dev. 2008 May;75(5):785-94.

PMID:
17948249
9.

IGF and myostatin pathways are respectively induced during the earlier and the later stages of skeletal muscle hypertrophy induced by clenbuterol, a β₂-adrenergic agonist.

Abo T, Iida RH, Kaneko S, Suga T, Yamada H, Hamada Y, Yamane A.

Cell Biochem Funct. 2012 Dec;30(8):671-6. doi: 10.1002/cbf.2848. Epub 2012 Jun 14.

PMID:
22696074
10.

Effects of the beta2-agonist clenbuterol on beta1- and beta2-adrenoceptor mRNA expressions of rat skeletal and left ventricle muscles.

Sato S, Nomura S, Kawano F, Tanihata J, Tachiyashiki K, Imaizumi K.

J Pharmacol Sci. 2008 Aug;107(4):393-400. Epub 2008 Aug 2.

11.

Nifedipine does not impede clenbuterol-stimulated muscle hypertrophy.

Murphy RJ, Béliveau L, Gardiner PF, Calderone A.

Proc Soc Exp Biol Med. 1999 Jul;221(3):184-7.

PMID:
10404034
12.

Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor.

Hinkle RT, Hodge KM, Cody DB, Sheldon RJ, Kobilka BK, Isfort RJ.

Muscle Nerve. 2002 May;25(5):729-34.

PMID:
11994968
13.

[Effect of a beta-agonist and a beta-agonist/beta-antagonist combination on muscle growth, body composition and protein metabolism in rats].

Reichel K, Rehfeldt C, Weikard R, Schadereit R, Krawielitzki K.

Arch Tierernahr. 1993;45(3):211-25. German.

PMID:
8585791
14.
15.

Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes.

Petrou M, Wynne DG, Boheler KR, Yacoub MH.

Circulation. 1995 Nov 1;92(9 Suppl):II483-9.

PMID:
7586459
17.

Metabolic and physiologic characteristics of skeletal muscle determine its response to clenbuterol treatment.

Sundal S, Katoch SS, Sharma S.

Indian J Biochem Biophys. 2006 Jun;43(3):160-6.

PMID:
16967905
18.

Effect of the beta 2-adrenergic agonist clenbuterol on the growth of fast- and slow-twitch skeletal muscle of the dystrophic (C57BL6J dy2J/dy2J) mouse.

Agbenyega ET, Morton RH, Hatton PA, Wareham AC.

Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1995 Jul;111(3):397-403.

PMID:
8564781
19.

Beta2-adrenergic agonist-induced hypertrophy of the quadriceps skeletal muscle does not modulate disease severity in the rodent meniscectomy model of osteoarthritis.

Tonge DP, Jones SW, Parr T, Bardsley R, Doherty M, Maciewicz RA.

Osteoarthritis Cartilage. 2010 Apr;18(4):555-62. doi: 10.1016/j.joca.2009.11.014. Epub 2009 Dec 21.

20.

Differential expression of skeletal muscle genes following administration of clenbuterol to exercised horses.

Knych HK, Harrison LM, Steinmetz SJ, Chouicha N, Kass PH.

BMC Genomics. 2016 Aug 9;17:596. doi: 10.1186/s12864-016-2945-2.

Supplemental Content

Support Center